Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Neurosciences

  • You have access
    Increased parietal amyloid burden and metabolic dysfunction in Alzheimer’s disease with early onset
    Rik Ossenkoppele, Marissa Zwan, Sofie Adriaanse, Frederik Barkhof, Ronald Boellaard, Albert Windhorst, Philip Scheltens, Adriaan Lammertsma, Wiesje van der Flier and Bart van Berckel
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 90;
  • You have access
    Imaging delayed cell death in subacute stroke with high-resolution 18F-Flumazenil
    Peter Zepper, Thomas Funck, Christian la Fougere, Alexey Kostikov, Ralf Schirrmacher and Alexander Thiel
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 37;
  • You have access
    Multicentre phase 3 trial on florbetaben for β-amyloid brain PET in Alzheimer disease
    Osama Sabri, Hiroyasu Akatsu, Yasuomi Ouchi, Kohei Senda, Shigeo Murayama, Kenji Ishii, Walter Schulz-Schaeffer, Katrin Roth, Cornelia Reininger and Marwan Sabbagh
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 41;
  • You have access
    Patterns of amyloid deposition and glucose metabolism in autosomal dominant AD: Comparison of quantification methods
    Yi Su, Tyler Blazey, Abraham Snyder, Marcus Raichle, John Morris and Tammie Benzinger
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 88;
  • You have access
    Evaluation of neuroinflammation in amyotrophic lateral sclerosis with 18F-DPA-714
    Maria-Joao Santiago-Ribeiro, Philippe Corcia, Clovis Tauber, Johnny Vercouillie, Yann Venel, Jean-Louis Baulieu, Serge Maia, Nicolas Arlicot, Michael Kassiou and Denis Guilloteau
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 35;
  • You have access
    Differentially decreased α4β2* nicotinic acetylcholine receptor availability (α4β2*-nAChR) in early-onset (EOAD) and late-onset Alzheimer’s disease (LOAD)
    Philipp Meyer, Hermann-Josef Gertz, Andreas Schildan, Julia Luthardt, Anita Seese, B. Sattler, Henryk Barthel, Swen Hesse and Osama Sabri
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 39;
  • You have access
    In vivo tau imaging in Alzheimer's disease
    Victor Villemagne, Shozo Furumoto, Michelle Fodero-Tavoletti, Rachel Mulligan, John Hodges, Yukitsuka Kudo, Colin Masters, Kazuhiko Yanai, Christopher Rowe and Nobuyuki Okamura
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 36;
  • You have access
    Clinical utility of flumazenil PET versus FDG PET and MRI in intractable epilepsy patients: Prospective study with a statistical parametric mapping method
    Hai-jeon Yoon, Ho-Young Lee, Hyejin Kang, Jarang Hahm, Byung Chul Lee and Sang Eun Kim
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 38;
  • You have access
    Ictal brain perfusion SPECT in the preoperative evaluation of intractable temporal lobe epilepsy
    Bingfeng Tang, Helena Balon, Darlene Fink and Oliver Wong
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1076;
  • You have access
    Diagnostic role of FDG PET in dementia
    Hussein Farghaly, Asif Moinuddin and Medhat Osman
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1077;

Pages

  • Previous
  • Next
  • 1
  • …
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
SNMMI

© 2025 SNMMI

Powered by HighWire